| HOME >> MEDICINE >> TECHNOLOGY |
$
,979,863$ 35,248,819Accounts receivable, net of allowance of $386,153 and $367,536 in 2011 and 2010, respectively
4,533,99013,915,569Current portion of long-term receivables
64,27130,800Inventories
5,866,5065,441,475Prepaid expenses and other current assets
3,314,8104,557,718Total current assets
30,759,44059,194,381Property and equipment, net
3,634,1853,840,622Intangible assets
2,354,1112,578,986Long-term receivables
81,514109,266Other assets
41,82138,537Total assets
$
36,871,071$ 65,761,792Liabilities and stockholders' equity (deficit)Current liabilities: Current maturities of long-term debt
$
28,992,163$ 20,894,091 Accounts payable
7,006,4958,796,182 Accrued liabilities
6,153,0886,966,571 Deferred contract revenue
8,180,8016,600,313 Warrants
289,9763,541,798Total current liabilities
50,622,52346,798,955Long-term debt, less current maturities
-8,000,000Long-term deferred contract revenue
335,296478,850Other liabilities
3,0948,741Stockholders' equity (deficit):Preferred stock, par value $0.001; 10,000,000 shares authorized at 2011 and 2010; none outstanding at 2011 and 2010
--Common stock, par value $0.001; 100,000,000 shares authorized at 2011 and 2010; 55,408,312 and 54,746,240 issued at 2011 and 2010, respectively
55,40854,746 Additional paid-in capital
355,954,708354,002,770 Treasury stock, 40,151 shares at 2011 and 2010
| SOURCE Stereotaxis, Inc. Copyright©2010 PR Newswire. All rights reserved |